Main menu

Targeted sequencing

Overview
Targeted sequencing document repository
558 Results
Brochure: microbiology and infectious disease researchBrochure

Brochure: microbiology and infectious disease research

In this brochure, discover Oxford Nanopore sequencing techniques that can reveal multidimensional insights for your microbial research applications.

Getting started guide: biopharmaGetting started guide

Getting started guide: biopharma

This guide introduces Oxford Nanopore sequencing solutions for biopharma that can be applied from biomarker discovery through to final product quality control (QC) testing.

Which library prep workflow is right for my experiment?Event video

Which library prep workflow is right for my experiment?

Whether you’re sequencing DNA, RNA, or cDNA, a single sample or many in multiplex, there’s an Oxford Nanopore library prep kit for you. In this masterclass, discover how ...

Ultra-rapid genomic profiling of pediatric brain tumors using whole-genome and targeted long-read sequencing | LC26Event video

Ultra-rapid genomic profiling of pediatric brain tumors using whole-genome and targeted long-read sequencing | LC26

The 2021 WHO classification of tumors of the central nervous system (CNS) made molecular testing and DNA methylation-based classification essential for diagnosing CNS tumors. However, traditional comprehensive genomic testing ...

Translating long-read sequencing into a scalable NHS bioinformatics workflow | LC26Event video

Translating long-read sequencing into a scalable NHS bioinformatics workflow | LC26

The North Thames Genomic Laboratory Hub is one of seven hubs providing National Health Service (NHS) genomic testing, including specialist testing for 14 disease areas for half of England. The ...

Targeted nanopore sequencing for newborn screening in a small population | LC26Event video

Targeted nanopore sequencing for newborn screening in a small population | LC26

Newborn screening (NBS) is a cornerstone of public health, originally established around biochemical detection of phenylketonuria and later expanded to include additional metabolic and genetic disorders. However, implementation of molecular ...

Targeted nanopore sequencing and an integrated analysis framework for neurogenomic disease | LC26Event video

Targeted nanopore sequencing and an integrated analysis framework for neurogenomic disease | LC26

Inherited neuromuscular and neurodegenerative disorders are difficult to diagnose due to extreme phenotypic and genetic heterogeneity. Key pathogenic mechanisms, including structural variation, short-tandem repeat (STR) expansions, and D4Z4 macrosatellite ...

Real-time nanopore methylation and genomic profiling for pediatric cancer | LC26Event video

Real-time nanopore methylation and genomic profiling for pediatric cancer | LC26

Nanopore-based DNA methylation profiling has become a clinically deployable platform for real-time molecular cancer diagnostics. In pediatric neuro-oncology, we pioneered intraoperative methylation-based classification using nanopore sequencing ...

Rapid diagnosis of acute leukemia with integrated epigenomic and genomic profiling | LC26Event video

Rapid diagnosis of acute leukemia with integrated epigenomic and genomic profiling | LC26

Acute leukemia (AL) diagnosis is a time-consuming process that requires integration of multiple different diagnostic modalities, including morphology, immunophenotyping, and molecular genetics. Given this complexity, new approaches are needed ...

Nanopore sequencing enables scalable, end-to-end quality control and capsid library profiling of recombinant AAV vectors | LC26Event video

Nanopore sequencing enables scalable, end-to-end quality control and capsid library profiling of recombinant AAV vectors | LC26

Recombinant adeno-associated viruses (rAAVs) are among the most widely used vectors for gene therapy, requiring stringent quality control to ensure vector integrity, safety, and therapeutic performance. Oxford Nanopore Technologies ...

How do I perform real-time targeted Oxford Nanopore sequencing?Event video

How do I perform real-time targeted Oxford Nanopore sequencing?

What if targeted sequencing took place during sequencing itself, without the need for special library prep, PCR, or probes? In this demo, discover Adaptive Sampling: a unique, real-time targeted ...

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditation

© 2008 - 2026 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, AmPORE-TB, EPI2ME, GridION, MinION, MinKNOW, PromethION, P2 Solo, and P2 are registered trademarks or the subject of trademark applications of Oxford Nanopore Technologies plc in various countries. Information contained herein may be protected by copyright, patents or patents pending of Oxford Nanopore Technologies plc. All other brands and names contained are the property of their respective owners. Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in‐vitro diagnostic devices in some jurisdictions, please check individual product labelling.

English flag